Coverage
-
August 11, 2015
A New York federal judge awarded $60 million in attorneys' fees Tuesday to Robbins Geller Rudman & Dowd LLP, lead counsel in a shareholder class action accusing Pfizer Inc. of misleading investors about off-label marketing of various drugs, less than two-thirds of the $94 million the firm had asked for.
10 other articles on this case.
View all »